U.S., Oct. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07201649) titled 'Roles of Hepatic Insufficiency, Hepatic Fibrosis, and Inorganic Pyrophosphate in the Progression of Arterial Calcifications' on Sept. 22.
Brief Summary: Individuals with metabolic syndrome (MetS), particularly those with type 2 diabetes (T2D), and/or metabolic dysfunction-associated steatohepatitis or MASH face an elevated risk of major cardiovascular events (MACE). We showed decrease plams level of PPi in patients with liver cirrhosis. We hypothezised that liver transplant should block AC and restore PPi plasma level.
Study Start Date: Oct. 30
Study Type: INTERVENTIONAL
Condition:
Liver Cirrhosis
Intervention:
OTHER: a blood t...